Raymond James Financial’s Elevation Oncology ELEV Stock Holding History

Raymond James Financial’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$1	–	5497
2025 Q2	$1	Buy	+2	New	+$1	﹤0.01%	6983

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Raymond James Financial's ELEV Position: Q3 2025 in Review

Raymond James Financial sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 2 shares — an estimated $1 sold.

Raymond James Financial first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $1 in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Raymond James Financial reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 2 Elevation Oncology shares in Q3 2025, an estimated $1.
Raymond James Financial first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Elevation Oncology position peaked at $1 in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.